Back
- 05
- Risks of whole brain radiation therapy added to radiosurgery outweigh benefits for patients with limited brain metastases
- Study identifies possible new combination chemotherapy for patients with advanced prostate cancer
- ASCO honors Allison for achievements in cancer immunotherapy
- MD Anderson receives $9 million in CPRIT research funding
- Study Finds Biomarker May Boost Ovarian Cancer Chemotherapy Response
- MD Anderson Making Cancer History® Seminar in Austin rescheduled for June 16
- Stereotactic Ablative Radiotherapy achieves better overall survival than surgery for early lung cancer
- Variations in liver cancer attributable to hepatitis virus variations
- Tumor sequencing study highlights benefits of profiling healthy tissue as well
- Protein FGL2 May Have Potential as Therapy Target for Brain Cancer
- Study May Suggest New Strategies for Myelodysplastic Syndromes Treatment
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.